Kestra Advisory Services, LLC Invitae Corp Transaction History

Kestra Advisory Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$14.7 - $28.67 $124,641 - $243,092	-8,479 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$24.31 - $33.6 $56,861 - $78,590	2,339 Added 38.09%	8,479 $241,000
Q2 2021 Jul 28, 2021	BUY	$26.09 - $40.4 $6,600 - $10,221	253 Added 4.3%	6,140 $207,000
Q1 2021 May 10, 2021	BUY	$33.06 - $56.93 $7,273 - $12,524	220 Added 3.88%	5,887 $224,000
Q4 2020 Jan 20, 2021	BUY	$39.09 - $57.4 $221,523 - $325,285	5,667 New	5,667 $250 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.